Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n=247) and in an adult control population (n=289) show increased fl/fl in short SGA

被引:61
作者
Audi, Laura
Esteban, Cristina
Carrascosa, Antonio
Espadero, Rosa
Perez-Arroyo, Annalisa
Arjona, Rosa
Clemente, Maria
Wollmann, Hartmut
Fryklund, Linda
Parodi, Luis A.
机构
[1] Hosp Valle De Hebron, Unidad Invest Endocrinol Pediat, Barcelona 08035, Spain
[2] Autonomous Univ Barcelona, Hosp Vall Hebron, Dept Pediat, Barcelona 08035, Spain
[3] Pfizer Spain, Med Unit, Madrid 28108, Spain
[4] Pfizer GmbH, WW Md Endocrine Care, D-76032 Karlsruhe, Germany
[5] Pfizer Inc, New York, NY 10017 USA
关键词
D O I
10.1210/jc.2006-0828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: A polymorphism in the human GH receptor gene (d3/fl-GHR) resulting in genomic deletion of exon 3 has been associated with the degree of height increase in response to GH therapy. Objective: The objective of the study was to evaluate the frequencies of d3/fl-GHR polymorphism genotypes in control and short small-for-gestational-age (SGA) populations. Design: An adult control population with heights normally distributed (ACPNH) between -2 and +2 SD score (SDS) and a short nonGH-deficient SGA child population were selected. Setting: Thirty Spanish hospitals participated in the selection of the short non-GH-deficient SGA children in the setting of a controlled, randomized trial, and one of these hospitals selected the ACPNH. Controls and Patients: Two hundred eighty-nine adult subjects of both sexes constituted the ACPNH and 247 children and adolescents of both sexes the short SGA patients. Main Outcome Measures: Heights and weights were recorded in the ACPNH, and auxologic and biochemical data were recorded at each hospital for the SGA patients; d3/fl-GHR genotypes were determined and data analyzed in a single hospital. Results: In short SGA patients, d3/fl-GHR genotype frequencies were significantly different from those in ACPNH, with a higher frequency of fl/fl genotype (P < 0.0001). In ACPNH, a trend toward diminished d3/d3 genotype frequency was observed in the shortest height group (Height <= -1 SDS and >= -2 SDS, n = 60). Conclusions: Our data showed significant differences in the frequency distribution of the d3/fl-GHR genotypes between a normally distributed adult height population and short SGA children, with the biologically less active fl/fl genotype being almost twice as frequent in SGA patients. These data suggest that the d3/fl-GHR polymorphism might be considered among the factors that contribute to the phenotypic expression of growth.
引用
收藏
页码:5038 / 5043
页数:6
相关论文
共 24 条
[1]   The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in turner syndrome and short small-for-gestational-age children [J].
Binder, G ;
Baur, F ;
Schweizer, R ;
Ranke, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :659-664
[2]  
Carrascosa A, 2004, An Pediatr (Barc), V60, P406
[3]   The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 μg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children:: Results from a two-year controlled prospective study in 170 Spanish patients [J].
Carrascosa, A. ;
Esteban, C. ;
Espadero, R. ;
Fernandez-Cancio, M. ;
Andaluz, P. ;
Clemente, M. ;
Audi, L. ;
Wollmann, H. ;
Fryklund, L. ;
Parodi, L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3281-3286
[4]  
Carrascosa Antonio, 2004, Med Clin (Barc), V123, P445, DOI 10.1157/13067078
[5]   HUMAN GROWTH-HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR - CRYSTAL-STRUCTURE OF THE COMPLEX [J].
DEVOS, AM ;
ULTSCH, M ;
KOSSIAKOFF, AA .
SCIENCE, 1992, 255 (5042) :306-312
[6]   A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone [J].
Dos Santos, C ;
Essioux, L ;
Teinturier, C ;
Tauber, M ;
Goffin, V ;
Bougnères, P .
NATURE GENETICS, 2004, 36 (07) :720-724
[7]  
Ferrandez A, 2005, Pediatr Endocr Rev, V2, P423
[8]   Continuing positive secular growth change in the Netherlands 1955-1997 [J].
Fredriks, AM ;
Van Buuren, S ;
Burgmeijer, RJF ;
Meulmeester, JF ;
Beuker, RJ ;
Brugman, E ;
Roede, MJ ;
Verloove-Vanhorick, SP ;
Wit, JM .
PEDIATRIC RESEARCH, 2000, 47 (03) :316-323
[9]   Assessing the impact of population stratification on genetic association studies [J].
Freedman, ML ;
Reich, D ;
Penney, KL ;
McDonald, GJ ;
Mignault, AA ;
Patterson, N ;
Gabriel, SB ;
Topol, EJ ;
Smoller, JW ;
Pato, CN ;
Pato, MT ;
Petryshen, TYL ;
Kolonel, LN ;
Lander, ES ;
Sklar, P ;
Henderson, B ;
Hirschhorn, JN ;
Altshuler, D .
NATURE GENETICS, 2004, 36 (04) :388-393
[10]   MUTATIONS OF THE GROWTH-HORMONE RECEPTOR IN CHILDREN WITH IDIOPATHIC SHORT STATURE [J].
GODDARD, AD ;
COVELLO, R ;
LUOH, SM ;
CLACKSON, T ;
ATTIE, KM ;
GESUNDHEIT, N ;
RUNDLE, AC ;
WELLS, JA ;
CARLSSON, LMS .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) :1093-1098